Literature DB >> 35223243

Mitral Valve Infective Endocarditis Complicated With Coronary Artery Embolization.

Cristina Carvalho Gouveia1, Inês Pimenta2, Marco Fernandes1, Beatriz Chambino1, Hugo Côrte-Real3.   

Abstract

Infective endocarditis is a multisystem and potentially fatal disease. Systemic embolization is a relatively common complication, the spleen and central nervous system being the most frequent sites for septic emboli formation. Coronary artery septic embolization is extremely uncommon and its management remains controversial. We present the case of a 50-year-old male diagnosed with mitral valve infective endocarditis complicated with spleen and central nervous system embolization, who developed acute myocardial infarction two weeks after disease onset. The patient was successfully treated with combined mitral valve replacement and coronary artery bypass grafting.
Copyright © 2022, Carvalho Gouveia et al.

Entities:  

Keywords:  coronary artery septic embolization; coronary revascularization; infective endocarditis; mitral valve replacement; systemic embolization

Year:  2022        PMID: 35223243      PMCID: PMC8860718          DOI: 10.7759/cureus.21459

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

Review 1.  An Unusual Acute Coronary Syndrome Due to a Septic Embolism: A Case Presentation and Review of Revascularization Strategies.

Authors:  Vassili Panagides; Marc Laine; Franck Paganelli; Laurent Bonello
Journal:  J Invasive Cardiol       Date:  2019-06       Impact factor: 2.022

Review 2.  Infective endocarditis complicated with coronary artery septic embolization: is it worth to be mentioned? Case presentation and review of the literature.

Authors:  Miklós Bitay; Sándor Varga; Barna Babik; Kálmán Havasi; Tamás Szücsborus
Journal:  Rev Cardiovasc Med       Date:  2019-03-30       Impact factor: 2.930

Review 3.  New approach to managing infective endocarditis.

Authors:  Fabio Chirillo
Journal:  Trends Cardiovasc Med       Date:  2020-05-11       Impact factor: 6.677

Review 4.  Bartonella Species, an Emerging Cause of Blood-Culture-Negative Endocarditis.

Authors:  Udoka Okaro; Anteneh Addisu; Beata Casanas; Burt Anderson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 5.  Management Considerations in Infective Endocarditis: A Review.

Authors:  Andrew Wang; Jeffrey G Gaca; Vivian H Chu
Journal:  JAMA       Date:  2018-07-03       Impact factor: 56.272

Review 6.  Managing embolic myocardial infarction in infective endocarditis: current options.

Authors:  Fida Khan; Rashida Khakoo; Conard Failinger
Journal:  J Infect       Date:  2004-11-11       Impact factor: 6.072

Review 7.  Infective Endocarditis: A Contemporary Review.

Authors:  Scott A Hubers; Daniel C DeSimone; Bernard J Gersh; Nandan S Anavekar
Journal:  Mayo Clin Proc       Date:  2020-04-13       Impact factor: 7.616

8.  [Acute coronary syndrome in infective endocarditis].

Authors:  María Carmen Manzano; Isidre Vilacosta; José A San Román; Paloma Aragoncillo; Cristina Sarriá; Daniel López; Javier López; Ana Revilla; Rocío Manchado; Rosana Hernández; Enrique Rodríguez
Journal:  Rev Esp Cardiol       Date:  2007-01       Impact factor: 4.753

9.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 10.  Infective endocarditis.

Authors:  Thomas J Cahill; Bernard D Prendergast
Journal:  Lancet       Date:  2015-09-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.